These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6289026)

  • 1. Naltrexone, opiate addiction, and endorphins.
    Gold MS; Dackis CA; Pottash AL; Sternbach HH; Annitto WJ; Martin D; Dackis MP
    Med Res Rev; 1982; 2(3):211-46. PubMed ID: 6289026
    [No Abstract]   [Full Text] [Related]  

  • 2. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Gold MS; Dackis CA; Washton AM
    Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rationale for opiate withdrawal symptomatology.
    Gold MS; Kleber HD
    Drug Alcohol Depend; 1979 Sep; 4(5):419-24. PubMed ID: 228923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of endorphins in opiate addiction, opiate withdrawal, and recovery.
    Gold MS; Rea WS
    Psychiatr Clin North Am; 1983 Sep; 6(3):489-520. PubMed ID: 6359093
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroanatomical sites of action of clonidine in opiate withdrawal: the locus coeruleus connection.
    Gold MS; Pottash AC; Extein IL; Kleber HD
    Prog Clin Biol Res; 1981; 71():285-98. PubMed ID: 6276897
    [No Abstract]   [Full Text] [Related]  

  • 6. Naltrexone for opioid addiction.
    Med Lett Drugs Ther; 1985 Feb; 27(680):11-2. PubMed ID: 3969057
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of narcotic antagonists in the rehabilitation of opiate addicts: a review of naltrexone.
    Schecter A
    Am J Drug Alcohol Abuse; 1980; 7(1):1-18. PubMed ID: 6254356
    [No Abstract]   [Full Text] [Related]  

  • 8. Psychiatric implications of endorphin research.
    Mackay AV
    Br J Psychiatry; 1979 Nov; 135():470-3. PubMed ID: 231991
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of naltrexone, a long-acting opiate antagonist.
    Crabtree BL
    Clin Pharm; 1984; 3(3):273-80. PubMed ID: 6329589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone in the treatment of opiate dependence.
    Resnick RB; Washton AM; Thomas MA; Kestenbaum RS
    NIDA Res Monogr; 1978; (19):321-32. PubMed ID: 218108
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of naloxone and naltrexone in different types of psychoses.
    Volavka J
    Mod Probl Pharmacopsychiatry; 1981; 17():202-12. PubMed ID: 6276726
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical relevance of opiate receptor and opioid peptide research.
    Snyder SH
    Nature; 1979 May; 279(5708):13-4. PubMed ID: 221824
    [No Abstract]   [Full Text] [Related]  

  • 13. Clonidine: inpatient studies from 1978 to 1981.
    Gold MS; Pottash AL; Extein I
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):35-8. PubMed ID: 7085583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid peptides and opiates differ in receptor selectivity.
    Terenius L
    Psychoneuroendocrinology; 1977; 2(1):53-8. PubMed ID: 198833
    [No Abstract]   [Full Text] [Related]  

  • 15. Naltrexone: a short-term treatment for opiate dependence.
    Greenstein RA; O'Brien CP; McLellan AT; Woody GE; Grabowski J; Long M; Coyle-Perkins G; Vittor A
    Am J Drug Alcohol Abuse; 1981; 8(3):291-300. PubMed ID: 7340503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the National Institute on Drug Abuse in the development of naltrexone.
    Ginzburg HM; Glass WJ
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):4-6. PubMed ID: 6088469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Opioid peptides and their receptors].
    Giros B; Schwartz JC
    Rev Prat; 1987 May; 37(29):1695-8, 1701-2. PubMed ID: 3035700
    [No Abstract]   [Full Text] [Related]  

  • 18. Withdrawal from endogenous opiates.
    Julius DA
    Am J Psychiatry; 1979 Mar; 136(3):358-9. PubMed ID: 420348
    [No Abstract]   [Full Text] [Related]  

  • 19. Strategies to improve compliance with narcotic antagonists.
    Kosten TR; Kleber HD
    Am J Drug Alcohol Abuse; 1984; 10(2):249-66. PubMed ID: 6475891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone reduces weight gain, alters "beta-endorphin", and reduces insulin output from pancreatic islets of genetically obese mice.
    Recant L; Voyles NR; Luciano M; Pert CB
    Peptides; 1980; 1(4):309-13. PubMed ID: 6272240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.